Overview

Assessment of Cardiac Fixation During PET Using a New Drug Within Amyloid Cardiac Injuries.

Status:
Terminated
Trial end date:
2019-09-15
Target enrollment:
Participant gender:
Summary
To estimate distribution's parameters of 18F-Flutemetamol (Vizamyl®) fixation on myocardium for patients with amyloid cardiac injuries.
Phase:
Early Phase 1
Details
Lead Sponsor:
University Hospital, Toulouse
Treatments:
Flutemetamol